0001574251-25-000003.txt : 20251008 0001574251-25-000003.hdr.sgml : 20251008 20251008140523 ACCESSION NUMBER: 0001574251-25-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251008 DATE AS OF CHANGE: 20251008 EFFECTIVENESS DATE: 20251008 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Mati Therapeutics Inc. CENTRAL INDEX KEY: 0001574251 ORGANIZATION NAME: EIN: 462000931 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-560168 FILM NUMBER: 251381934 BUSINESS ADDRESS: STREET 1: 4317 DUNNING LANE CITY: AUSTIN STATE: TX ZIP: 78746 BUSINESS PHONE: (512) 329-6360 MAIL ADDRESS: STREET 1: 4317 DUNNING LANE CITY: AUSTIN STATE: TX ZIP: 78746 D 1 primary_doc.xml X0708 D LIVE 0001574251 Mati Therapeutics Inc. 101 Colorado Street Suite 2409 AUSTIN TX TEXAS 78701 (512) 720-1333 DELAWARE 10152012, Inc. None Corporation true Robert Butchofsky 101 Colorado Street Suite 2409 Austin TX TEXAS 78701 Executive Officer Director Christopher Muller 101 Colorado Street Suite 2409 Austin TX TEXAS 78701 Executive Officer Director Deepank Utkhede 101 Colorado Street Suite 2409 Austin TX TEXAS 78701 Director Joseph Tortorice III 101 Colorado Street Suite 2409 Austin TX TEXAS 78701 Director Cameron Nelson 101 Colorado Street Suite 2409 Austin TX TEXAS 78701 Executive Officer Biotechnology Decline to Disclose 06b false 2025-09-30 false true true revenue share false 0 10523695 9867695 656000 false 13 0 0 0 false Mati Therapeutics Inc. Robert Butchofsky Robert Butchofsky Chief Executive Officer 2025-10-08